The late breaking abstract program allows for inclusion of later submissions of newly completed research and clinical trials. The abstract should describe a noteworthy and timely research advance that has not been previously published or submitted.

Submissions will be accepted until Monday, March 15, 2021, at 5:00 PM ET.